Javascript must be enabled to continue!
Clinical Pathway -- to follow or not to follow
View through CrossRef
Background and Objective: Clinical Pathways are expected to make health
care delivery more efficient and effective. Yet we have very little
research on how Clinical Pathways are followed. This study assesses the
functioning of a Clinical Pahway for elderly people in a Finnish case.
At the same time it documents the hardships of getting information on
the patient flows in a Clinical Pathway. Study Design/Materials and
Methods: The data on all patients aged 75 years or more who had visited
the emergency unit of the city hospital in 2006–2008 was collected. The
study sample comprised 24,195 admissions. The flow of patients after the
first care at the emergency unit was analysed, collecting data from
various scattered sources. Results: The results show that the planned
Patient Pathways seem not to be followed always. Yearly about 17% of
the patients were referred to the university hospital, the more
expensive care, but about 74% of these referrals did not follow the
agreed procedure. The excess costs of referring patients to a
non-standard, more expensive Clinical Pathway were 2,57 Million Euros
over a period of three years for the studied population of 24,195
admissions, also averaging 106 Euros per admission. Conclusion: Clinical
Pathways were not followed in the case as planned and expected. Reasons
for this should be better understood and studied in more depth. In
addition, follow-up information of Clinical Pathway flows is often hard
to collect because of fragmented information systems, that are not
designed to document patient flows in Clinical Pathways.
Title: Clinical Pathway -- to follow or not to follow
Description:
Background and Objective: Clinical Pathways are expected to make health
care delivery more efficient and effective.
Yet we have very little
research on how Clinical Pathways are followed.
This study assesses the
functioning of a Clinical Pahway for elderly people in a Finnish case.
At the same time it documents the hardships of getting information on
the patient flows in a Clinical Pathway.
Study Design/Materials and
Methods: The data on all patients aged 75 years or more who had visited
the emergency unit of the city hospital in 2006–2008 was collected.
The
study sample comprised 24,195 admissions.
The flow of patients after the
first care at the emergency unit was analysed, collecting data from
various scattered sources.
Results: The results show that the planned
Patient Pathways seem not to be followed always.
Yearly about 17% of
the patients were referred to the university hospital, the more
expensive care, but about 74% of these referrals did not follow the
agreed procedure.
The excess costs of referring patients to a
non-standard, more expensive Clinical Pathway were 2,57 Million Euros
over a period of three years for the studied population of 24,195
admissions, also averaging 106 Euros per admission.
Conclusion: Clinical
Pathways were not followed in the case as planned and expected.
Reasons
for this should be better understood and studied in more depth.
In
addition, follow-up information of Clinical Pathway flows is often hard
to collect because of fragmented information systems, that are not
designed to document patient flows in Clinical Pathways.
Related Results
Abstract 920: COP1 E3 ligase regulates response to oncogenic MAPK pathway inhibition
Abstract 920: COP1 E3 ligase regulates response to oncogenic MAPK pathway inhibition
Abstract
Oncogenically activated RAS-MAPK pathway is the driver of several cancers including the majority of non-small cell lung adenocarcinomas (NSCLC). RAS-MAPK pa...
Abstract 705: Elucidating pediatric brain tumor pathophysiology by assessing signal transduction pathway activation
Abstract 705: Elucidating pediatric brain tumor pathophysiology by assessing signal transduction pathway activation
Abstract
A major problem in pediatric neuro-oncology is lack of insight into underlying tumor biology, making treatment with targeted therapy challenging for this gr...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Thyroid Hemiagenesis: A Single-Center Case Series
Thyroid Hemiagenesis: A Single-Center Case Series
Abstract
Introduction: Thyroid hemiagenesis (TH) is a rare congenital anomaly characterized by the complete absence of one thyroid lobe, with or without absence of the isthmus. Its...
Abstract 2271: Patient-specific visualization of cancer pathways
Abstract 2271: Patient-specific visualization of cancer pathways
Abstract
Introduction: Analysis of whole transcriptomics datasets to quantify gene expression and determine differentially expressed genes has provided valuable inf...
Using set theory to reduce redundancy in pathway sets
Using set theory to reduce redundancy in pathway sets
1.
Abstract
1.01
Background
The consolidation of pathway databases, such as KEGG[1], Reactome...
The CML-Microvesicles Are Enriched with Mirnas Regulating MAPK Signaling Pathway.
The CML-Microvesicles Are Enriched with Mirnas Regulating MAPK Signaling Pathway.
Abstract
Abstract 2786
Leukemia-cell-derived microvesicles (MVs) act as vehicles for exchange of genetic information between leukemia and nomal cells,...
Abstract 1510: The sonic hedgehog pathway as a therapeutic target in bladder cancer
Abstract 1510: The sonic hedgehog pathway as a therapeutic target in bladder cancer
Abstract
Introduction:
The sonic hedgehog (SHH) signaling pathway regulates embryonic developmental processes such as pattern formation, differentiati...

